Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
symbol | company | %chng | last | %short | avg$volume | |
---|---|---|---|---|---|---|
VRX | Valeant Pharmaceuticals International, Inc. | -1.74% | 26.53 | 14.1% | $156.11m | |
HZNP | Horizon Therapeutics Plc | -4.51% | 74.97 | 5.6% | $145.18m | |
ACRS | Aclaris Therapeutics, Inc. | -0.91% | 17.48 | 4.7% | $128.70m | |
BHC | Bausch Health Cos., Inc. | -1.74% | 26.53 | 0.0% | $109.30m | |
CTLT | Catalent, Inc. | -2.08% | 113.32 | 2.1% | $104.54m | |
JAZZ | Jazz Pharmaceuticals Plc | -2.88% | 166.05 | 2.4% | $86.52m | |
SAVA | Cassava Sciences, Inc. | 23.92% | 19.43 | 0.0% | $69.29m | |
AMRN | Amarin Corp. Plc | -1.06% | 7.48 | 1.5% | $62.88m | |
UTHR | United Therapeutics Corp. | -2.66% | 164.85 | 14.1% | $59.11m | |
ISR | IsoRay, Inc. | -4.09% | 2.11 | 2.5% | $56.26m | |
GWPH | GW Pharmaceuticals Plc | 4.77% | 150.23 | 6.1% | $55.26m | |
PRGO | Perrigo Co. Plc | 0.00% | 44.50 | 6.8% | $53.91m | |
ACST | Acasti Pharma, Inc. | -4.20% | 0.73 | 0.2% | $53.14m | |
ARGX | argenx SE | -4.55% | 300.99 | 0.0% | $50.83m | |
ICPT | Intercept Pharmaceuticals, Inc. | 1.93% | 33.78 | 16.8% | $43.62m |
Company Profile
CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.